{"id":"https://openalex.org/W4388047907","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0730","title":"730 A phase I safety and tolerability study of VAXinia (CF33-hNIS), a novel chimeric oncolytic poxvirus, administered intratumorally or intravenously in adults with metastatic or advanced solid tumors","display_name":"730 A phase I safety and tolerability study of VAXinia (CF33-hNIS), a novel chimeric oncolytic poxvirus, administered intratumorally or intravenously in adults with metastatic or advanced solid tumors","publication_year":2023,"publication_date":"2023-10-31","ids":{"openalex":"https://openalex.org/W4388047907","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0730"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0730","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0730","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0730","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/825.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/825.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037942451","display_name":"Daneng Li","orcid":"https://orcid.org/0000-0001-5330-7522","observed_orcids":["https://orcid.org/0000-0001-5330-7522"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]},{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daneng Li","raw_affiliation_strings":["City of Hope, Duarte, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope, Duarte, CA, USA","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044613951","display_name":"Alexander I. Spira","orcid":"https://orcid.org/0000-0003-1303-0447","observed_orcids":["https://orcid.org/0000-0003-1303-0447"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexander I Spira","raw_affiliation_strings":["Next Oncology, Fairfax, VA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Next Oncology, Fairfax, VA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023904148","display_name":"Hirva Mansurali Mamdani","orcid":"https://orcid.org/0000-0003-3874-8703","observed_orcids":["https://orcid.org/0000-0003-3874-8703"]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]},{"id":"https://openalex.org/I4210090317","display_name":"The Barbara Ann Karmanos Cancer Institute","ror":"https://ror.org/00ee40h97","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800590384","https://openalex.org/I4210090317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hirva Mamdani","raw_affiliation_strings":["Barbara Ann Karmanos Cancer Institute/Wayne State University, Detroit, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barbara Ann Karmanos Cancer Institute/Wayne State University, Detroit, MI, USA","institution_ids":["https://openalex.org/I185443292","https://openalex.org/I4210090317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072085953","display_name":"Jennifer L. Leddon","orcid":"https://orcid.org/0000-0002-9953-0882","observed_orcids":["https://orcid.org/0000-0002-9953-0882"]},"institutions":[{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Leddon","raw_affiliation_strings":["University of Cincinnati, Cincinnati, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Cincinnati, Cincinnati, OH, USA","institution_ids":["https://openalex.org/I63135867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005824918","display_name":"Yuman Fong","orcid":"https://orcid.org/0000-0002-8934-9959","observed_orcids":["https://orcid.org/0000-0002-8934-9959"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]},{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yuman Fong","raw_affiliation_strings":["City of Hope, Duarte, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope, Duarte, CA, USA","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114036453","display_name":"Leslie Mi Ok Chong","orcid":"https://orcid.org/0009-0006-6795-4417","observed_orcids":["https://orcid.org/0009-0006-6795-4417"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leslie Chong","raw_affiliation_strings":["Imugene Ltd, Sydney, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imugene Ltd, Sydney, NSW, Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085939676","display_name":"Seymour H. Fein","orcid":"https://orcid.org/0000-0001-8054-200X","observed_orcids":["https://orcid.org/0000-0001-8054-200X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seymour Fein","raw_affiliation_strings":["Imugene Ltd, Sydney, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imugene Ltd, Sydney, NSW, Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104111067","display_name":"Nick Ede","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nick Ede","raw_affiliation_strings":["Imugene Ltd, Sydney, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imugene Ltd, Sydney, NSW, Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047012835","display_name":"Ursula McCurry","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ursula McCurry","raw_affiliation_strings":["Imugene Ltd, Sydney, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imugene Ltd, Sydney, NSW, Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078374050","display_name":"Amanda Seiz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amanda Seiz","raw_affiliation_strings":["Imugene Ltd, Sydney, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imugene Ltd, Sydney, NSW, Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078062122","display_name":"Melissa J. Polasek","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melissa Polasek","raw_affiliation_strings":["Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chapel Hill, NC, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026474154","display_name":"Sharon Yavrom","orcid":"https://orcid.org/0009-0000-6681-9762","observed_orcids":["https://orcid.org/0009-0000-6681-9762"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sharon Yavrom","raw_affiliation_strings":["Imugene Ltd, Sydney, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imugene Ltd, Sydney, NSW, Australia","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028773984","display_name":"Giovanni Selvaggi","orcid":"https://orcid.org/0000-0001-8015-8999","observed_orcids":["https://orcid.org/0000-0001-8015-8999"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giovanni Selvaggi","raw_affiliation_strings":["Imugene Ltd, Sydney, NSW, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imugene Ltd, Sydney, NSW, Australia","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A825","last_page":"A825"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nis","display_name":"Ni","score":0.9010000228881836},{"id":"https://openalex.org/keywords/oncolytic-poxvirus","display_name":"oncolytic poxvirus","score":0.9020000100135803},{"id":"https://openalex.org/keywords/sodium-iodide-symporter","display_name":"sodium iodide symporter","score":0.8640000224113464},{"id":"https://openalex.org/keywords/spect-imaging","display_name":"SPECT imaging","score":0.7279999852180481},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9639999866485596},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.597000002861023},{"id":"https://openalex.org/keywords/metastatic-solid-tumors","display_name":"metastatic solid tumors","score":0.8130000233650208},{"id":"https://openalex.org/keywords/intratumoral-administration","display_name":"intratumoral administration","score":0.8389999866485596},{"id":"https://openalex.org/keywords/intravenous-administration","display_name":"intravenous administration","score":0.9539999961853027},{"id":"https://openalex.org/keywords/viral-shedding","display_name":"viral shedding","score":0.621999979019165},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.6520000100135803},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.5690000057220459},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5920000076293945},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.859000027179718}],"concepts":[{"id":"https://openalex.org/C82210918","wikidata":"https://www.wikidata.org/wiki/Q1560099","display_name":"Oncolytic virus","level":3,"score":0.86250901222229},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6876670718193054},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5524140000343323},{"id":"https://openalex.org/C34981463","wikidata":"https://www.wikidata.org/wiki/Q3311663","display_name":"Suicide gene","level":4,"score":0.49196168780326843},{"id":"https://openalex.org/C111599444","wikidata":"https://www.wikidata.org/wiki/Q213901","display_name":"Genetic enhancement","level":3,"score":0.405489444732666},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3777267038822174},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.323827862739563},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.14557993412017822},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2023-sitc2023.0730","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0730","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0730","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/825.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:8d18a0d35fb643a68cee3c39228afbff","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/8d18a0d35fb643a68cee3c39228afbff","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0730","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0730","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0730","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/825.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388047907.pdf","grobid_xml":"https://content.openalex.org/works/W4388047907.grobid-xml"},"referenced_works_count":4,"referenced_works":["https://openalex.org/W2797742916","https://openalex.org/W2801911075","https://openalex.org/W2951600248","https://openalex.org/W3008677330"],"related_works":["https://openalex.org/W3083702063","https://openalex.org/W4393988563","https://openalex.org/W4200551205","https://openalex.org/W4391091370","https://openalex.org/W4362594857","https://openalex.org/W4281765131","https://openalex.org/W4413618968","https://openalex.org/W4322771972","https://openalex.org/W2939244549","https://openalex.org/W4387808207"],"abstract_inverted_index":{"Background":[0],"CF33":[1,70,76],"is":[2,17,168,200,223,302,323],"a":[3,91,111,119,169,470,503],"novel":[4],"chimeric":[5,426,457],"oncolytic":[6,270,456],"poxvirus,":[7],"encoding":[8],"the":[9,22,28,66,75,131,176,219,382,520],"human":[10],"Sodium-Iodide":[11],"Symporter":[12],"(hNIS)":[13],"transgene.":[14],"The":[15,40,63,103,278,318,335,514],"transgene":[16,67],"inserted":[18],"in":[19,32,37,45,100,118,148,152,186,190,202,340,381,438,502],"place":[20],"of":[21,34,65,74,83,98,105,139,164,178,211,257,296,406,461],"viral":[23,35,291],"thymidine":[24],"kinase":[25],"gene":[26],"at":[27,469,526],"J2R":[29,429],"locus,":[30],"resulting":[31],"attenuation":[33],"replication":[36],"normal":[38],"cells.":[39],"engineered":[41],"virus":[42,77],"selectively":[43],"replicates":[44],"tumor":[46,51,101,113,297,493],"cells":[47],"and":[48,56,59,86,95,115,133,142,207,222,283,294,308,329,351,373,435,465,496],"leads":[49],"to":[50,227,305],"cell":[52],"lysis,":[53],"releasing":[54],"tumor-":[55],"virus-associated":[57],"antigens":[58],"stimulating":[60],"antitumor":[61],"immunity.":[62],"expression":[64,97],"hNIS":[68],"with":[69,78,150,188,192,268,428,499],"allows":[71],"for":[72,218,326,332],"imaging":[73],"SPECT.":[79],"In":[80],"preclinical":[81,120],"models":[82],"colon,":[84],"lung,":[85],"pancreatic":[87,462],"cancer,":[88],"CF33-hNIS":[89,106,145,179,199,327],"demonstrated":[90],"robust":[92],"anti-tumor":[93,436],"response":[94,289],"enhanced":[96],"PD-L1":[99],"cells.1\u20133":[102],"combination":[104,149,187,220,333,353,370,375],"+":[107],"anti-PD-L1":[108,500],"therapy":[109],"showed":[110],"synergistic":[112],"killing,":[114],"increased":[116],"survival":[117],"triple":[121],"negative":[122],"breast":[123,505],"cancer":[124,440,463,506],"(TNBC)":[125],"model.4":[126],"This":[127,167],"study":[128,174,234,336,515,530],"will":[129,230],"evaluate":[130],"safety":[132,177,282,434],"recommended":[134],"Phase":[135],"2":[136,254],"dose":[137],"(RP2D)":[138],"intratumoral":[140],"(IT)":[141],"intravenous":[143],"(IV)":[144],"alone":[146,184],"or":[147,154,182,185,194,247],"pembrolizumab":[151,189],"advanced":[153,193,246],"metastatic":[155,195,248],"solid":[156,196,249],"tumors,":[157],"after":[158,252],"progression":[159,251],"following":[160],"\u22652":[161],"prior":[162,255],"lines":[163,256],"therapy.":[165],"Methods":[166],"dose-escalation,":[170],"multi-center":[171],"phase":[172],"1":[173,260,355,377],"evaluating":[175],"administered":[180,201,224],"IT":[181,347,365,374],"IV,":[183],"patients":[191,229,339],"tumors":[197],"(NCT05346484).":[198],"21-day":[203],"cycles":[204],"on":[205],"C1D1":[206],"C1D8,":[208],"then":[209],"D1":[210],"each":[212,527],"cycle":[213],"thereafter.":[214],"Pembrolizumab":[215],"begins":[216],"C2D1":[217],"groups":[221],"Q3W.":[225],"Up":[226],"100":[228],"be":[231],"enrolled":[232],"across":[233],"groups.":[235],"Key":[236,263],"inclusion":[237],"criteria:":[238,265],"age":[239],"\u2265":[240,253,259],"18":[241],"years;":[242],"ECOG":[243],"0\u20132;":[244],"confirmed":[245],"tumor;":[250],"therapy;":[258],"measurable":[261],"lesion.":[262],"exclusion":[264],"previous":[266],"treatment":[267,314],"an":[269],"virus;":[271],"systemic":[272],"steroid":[273],"treatment;":[274],"uncontrolled":[275],"brain/CNS":[276],"metastases.":[277],"co-primary":[279],"endpoints":[280,286],"are":[281,378],"RP2D.":[284],"Secondary":[285],"include":[287],"objective":[288],"rate,":[290],"shedding":[292],"titers,":[293],"level":[295],"infection":[298],"by":[299,519],"CF33-hNIS.":[300],"Response":[301],"determined":[303],"according":[304],"RECIST":[306],"v1.1":[307],"iRECIST":[309],"criteria.":[310],"Patients":[311],"may":[312],"receive":[313],"until":[315],"disease":[316],"progression.":[317],"dose-limiting":[319],"toxicity":[320],"(DLT)":[321],"window":[322],"28":[324],"days":[325,331],"monotherapy":[328,344,348,362,366],"42":[330],"treatment.":[334],"began":[337],"enrolling":[338,380],"March":[341],"2022;":[342],"IV":[343,352,361,369],"cohorts":[345,349],"1\u20133,":[346],"1\u20132,":[350],"cohort":[354,363,367,371,376],"have":[356],"been":[357,517],"completed":[358],"without":[359],"DLTs.":[360],"4,":[364],"3,":[368],"2,":[372],"currently":[379],"US.":[383],"Trial":[384],"Registration":[385],"NCT05346484":[386],"References":[387],"O\u2019Leary":[388,447],"MP,":[389,448],"Warner":[390],"SG,":[391],"Kim":[392,451],"SI,":[393,452],"et":[394,423,453,486],"al.":[395,424,454,487],"A":[396,425],"Novel":[397,455],"Oncolytic":[398,488],"Chimeric":[399],"Orthopoxvirus":[400],"Encoding":[401],"Luciferase":[402],"Enables":[403],"Real-Time":[404],"View":[405],"Colorectal":[407],"Cancer":[408,442],"Cell":[409],"Infection.":[410],"Mol":[411],"Ther":[412],"Oncolytics.":[413],"2018":[414,477],"Mar":[415],"22;9:13\u201321.":[416],"Chaurasiya":[417,480],"S,":[418,481,485],"Chen":[419],"NG,":[420],"Lu":[421],"J,":[422],"poxvirus":[427,489],"(thymidine":[430],"kinase)":[431],"deletion":[432],"shows":[433],"activity":[437],"lung":[439],"models.":[441],"Gene":[443],"Ther.":[444],"2020":[445,509],"Apr;27(3\u20134):125\u2013135.":[446],"Choi":[449],"AH,":[450],"orthopoxvirus":[458],"causes":[459],"regression":[460],"xenografts":[464],"exhibits":[466],"abscopal":[467],"effect":[468],"single":[471],"low":[472],"dose.":[473],"J":[474],"Transl":[475],"Med.":[476],"Apr":[478],"26;16(1):110.":[479],"Yang":[482],"A,":[483],"Kang":[484],"CF33-hNIS-\u0394F14.5":[490],"favorably":[491],"modulates":[492],"immune":[494],"microenvironment":[495],"works":[497],"synergistically":[498],"antibody":[501],"triple-negative":[504],"model.":[507],"Oncoimmunology.":[508],"Feb":[510],"24;9(1):1729300.":[511],"Ethics":[512,524],"Approval":[513],"has":[516],"approved":[518],"Institutional":[521],"Review":[522],"Board/Independent":[523],"Committee":[525],"site.":[528],"All":[529],"participants":[531],"provide":[532],"written":[533],"informed":[534],"consent":[535],"before":[536],"enrollment.":[537]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2023-11-01T00:00:00"}